乳腺癌生物学预后因子的研究进展

被引:5
作者
张杰
邵志敏
沈镇宙
机构
[1] 复旦大学附属肿瘤医院乳腺外科
关键词
乳腺癌; 生物学因子; 预后因子;
D O I
暂无
中图分类号
R737.9 [乳腺肿瘤];
学科分类号
100214 ;
摘要
乳腺癌是多步骤发生的疾病,存在多个生物学因子的异常。研究生物学预后因子不仅能发现临床病理学指标不能发现的部分易复发患者,而且有助于实施乳腺癌的个体化治疗。本文综述乳腺癌生物学预后因子,如Her-2/neu、P53、BRCA1、血管生成因子(angiogenesis)杂合性丢失(LOH)等的最新进展。
引用
收藏
页码:465 / 469
页数:5
相关论文
共 7 条
[1]   乳腺癌细胞凋亡及相关基因表达的预后研究 [J].
吴炅 ;
沈镇宙 ;
邵志敏 .
上海医学, 1999, (01) :26-30
[2]   Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome [J].
Foulkes, WD ;
Chappuis, PO ;
Wong, N ;
Brunet, JS ;
Vesprini, D ;
Rozen, F ;
Yuan, ZQ ;
Pollak, MN ;
Kuperstein, G ;
Narod, SA ;
Bégin, LR .
ANNALS OF ONCOLOGY, 2000, 11 (03) :307-313
[3]   New prognostic factors associated with long-term survival in node-negative breast cancer patients [J].
Kato T. ;
Kimura T. ;
Takami N. ;
Miyakawa R. ;
Tanaka S. ;
Muraici H. ;
Kamio T. ;
Fujii A. ;
Yamamoto K. ;
Kameoka S. ;
Nishikawa T. ;
Kasajima T. .
Breast Cancer, 1999, 6 (4) :370-377
[4]   Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer? [J].
Degeorges, A ;
de Roquancourt, A ;
Extra, JM ;
Espie, M ;
Bourstyn, E ;
de Cremoux, P ;
Soussi, T ;
Marty, M .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (01) :47-55
[5]  
Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment[J] . Els M.J.J. Berns,John A. Foekens,Iris L. van Staveren,Wim L.J. van Putten,Helen Y.W.C.M. de Koning,Henk Portengen,Jan G.M. Klijn.Gene . 1995 (1)
[6]  
Epidermal growth factor receptor expression in breast cancer: Association with response to endocrine therapy[J] . Robert I. Nicholson,Richard A. McClelland,Julia M. W. Gee,David L. Manning,Peter Cannon,John F. R. Robertson,Ian O. Ellis,Roger W. Blamey.Breast Cancer Research and Treatment . 1994 (1)
[7]  
HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study. Elledge RM, Green S, Ciocca D, et al. Clinical Cancer Research . 1998